Kejun Liu
Yinchuan, 750004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
CARS1 as a Prognostic Biomarker and Candidate Therapeutic Vulnerability in Hepatocellular Carcinoma: Insights Into Tumor Progression and the Immune Microenvironment.
Journal: Frontiers in bioscience (Landmark edition)
Published: May 07, 2026
PUM1 Promotes HCC Cell Proliferation and Inhibits Mitochondria‑mediated Apoptosis, Accompanied by Activation of the PI3K-AKT Pathway.
Journal: Journal of hepatocellular carcinoma
Published: May 06, 2026
The Prognostic and Biological Value of PGF-Based H&E Pathomics in Hepatocellular Carcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 23, 2025
Improving pancreatic adenocarcinoma prognosis models through ligand receptor interactions and histopathological integration.
Journal: Journal of translational medicine
Published: September 22, 2025
Study on the Mechanism of CCN2 Promoting Sorafenib Resistance in HCC and Its Combined Intervention Strategy.
Journal: Frontiers in bioscience (Landmark edition)
Published: July 31, 2025
BRG1 promotes liver cancer cell proliferation and metastasis by enhancing mitochondrial function and ATP5A1 synthesis through TOMM40.
Journal: Cancer biology & therapy
Published: July 09, 2024
Risk prediction for dermatomyositis-associated hepatocellular carcinoma.
Journal: BMC bioinformatics
Published: February 02, 2023
Nonalcoholic Fatty Liver Hepatocyte-Derived lncRNA MALAT1 Aggravates Pancreatic Cell Inflammation via the Inhibition of Autophagy by Upregulating YAP.
Journal: Computational intelligence and neuroscience
Published: July 09, 2022
Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker.
Journal: Frontiers in genetics
Published: April 18, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026